You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Epic Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for EPIC PHARMA, and what generic and branded alternatives to EPIC PHARMA drugs are available?

EPIC PHARMA has one hundred and eighty-eight approved drugs.

There is one tentative approval on EPIC PHARMA drugs.

Summary for Epic Pharma
US Patents:0
Tradenames:155
Ingredients:146
NDAs:188

Drugs and US Patents for Epic Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 077507-001 Oct 27, 2005 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 200294-001 Apr 13, 2012 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc ZONISAMIDE zonisamide CAPSULE;ORAL 077876-001 Feb 21, 2007 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.